Innophos expands excipient portfolio

Published: 4-Dec-2019
Ingredients

US-based Innophos has added new co-processed, multifunctional excipients for pharmaceutical and nutraceutical tablet and capsule formulations to its portfolio

Innophos expands excipient portfolio
Photo as seen on company website

Photo as seen on company website

Innophos has expanded its portfolio with new co-processed, multifunctional excipients for pharmaceutical and nutraceutical tablet and capsule formulations. A-Tab MD is a label-friendly, multifunctional excipient demonstrated to enhance compressibility and simplify formulations.

The benefits of A-Tab MD mean formulators can improve manufacturing efficiency, improve performance, and deliver smaller tablet sizes to meet consumer preferences.

Innophos’s portfolio of co-processed, multifunctional excipients also includes Nutra-Tab and Tri-Tab PVP.

“A-Tab MD delivers important value to manufacturers and consumers alike,” said Sherry Duff, Innophos’ SVP, Chief Marketing Officer, and Chief Technology Officer.

See more

You may also like

Ingredients
UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

Read more
The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals

Trending Articles

  1. Resonant clinical solutions and Haier Biomedical introduce an innovative Benchtop centrifuge with a nantural refrigerant Resonant Clinical Solutions – a global clinical solutions partner serving life sciences organisations across the clinical supply chain and sample lifecycle – and Haier Biomedical – a trusted leader in reliable and sustainable laboratory equipment – have launched an innovative benchtop centrifuge using a natural refrigerant
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Performance validation: HPAPI containment testing in a risk-based era Taking a more automated approach to validation testing paves the way to capturing more repeatable and reliable data, thereby improving levels of containment performance
  3. UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals
  4. Promega unveils cellular target engagement technology TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery
  5. Patented device reinvents solid phase extraction SPEedy provides controlled SPE sample preparation without the need for an external vacuum

You may also like

Ingredients
UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

UKHSA to investigate PFAS exposure in UK population as pharma industry faces regulatory scrutiny

The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical manufacturers face growing pressure around the use of forever chemicals
Ingredients
Resonant clinical solutions and Haier Biomedical introduce an innovative Benchtop centrifuge with a nantural refrigerant

Resonant clinical solutions and Haier Biomedical introduce an innovative Benchtop centrifuge with a nantural refrigerant

Resonant Clinical Solutions – a global clinical solutions partner serving life sciences organisations across the clinical supply chain and sample lifecycle – and Haier Biomedical – a trusted leader in reliable and sustainable laboratory equipment – have launched an innovative benchtop centrifuge using a natural refrigerant
Manufacturing
Turning commitments into measurable progress

Turning commitments into measurable progress

CARBOGEN AMCIS publishes first CSR Report
Ingredients
Indena to showcase its integrated European platform for HPAPIs and complex molecules at CPHI Milan 2026

Indena to showcase its integrated European platform for HPAPIs and complex molecules at CPHI Milan 2026

The leading unit CDMO will highlight breakthroughs in ADC payloads, ultra-high containment spray drying, and its strategic QS-21 partnership
Ingredients
C2 Pharma launches brinzolamide ophthalmic API

C2 Pharma launches brinzolamide ophthalmic API

C2 Pharma has added brinzolamide to its ophthalmic API portfolio following completion of process validation and submission of a US Drug Master File
Ingredients
dsm-firmenich launches Biond pharmaceutical-grade vitamin portfolio for cell culture and biologics manufacturing

dsm-firmenich launches Biond pharmaceutical-grade vitamin portfolio for cell culture and biologics manufacturing

The range targets critical metabolic pathways supporting cell growth, viability and protein expression — available globally through Brenntag's BYPHAR distribution network ahead of its CPHI Milan debut
Manufacturing
CARBOGEN AMCIS announces successful first FDA pre-approval inspection at its Vionnaz site

CARBOGEN AMCIS announces successful first FDA pre-approval inspection at its Vionnaz site

CARBOGEN AMCIS part of the Dishman Carbogen Amcis Group, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of the first U.S. Food and Drug Administration (FDA) Pre-Approval Inspection (PAI) at its Vionnaz facility in Switzerland. The inspection concluded without the issuance of a Form 483
Subscribe now